HC Wainwright & Co. Reiterates Buy on Edesa Biotech, Maintains $21 Price Target
EDESA BIOTECH INC 0.00% Pre
EDESA BIOTECH INC EDSA | 3.40 3.40 | 0.00% 0.00% Pre |
HC Wainwright & Co. analyst Vernon Bernardino reiterates Edesa Biotech (NASDAQ:
EDSA) with a Buy and maintains $21 price target.